Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

308
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
308
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Neural Regulation01:37

Neural Regulation

39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Stakeholders' Perspectives on Parkinson Disease Management and Digital Technologies: Exploratory International Survey.

JMIR formative research·2026
Same author

Phenotypic spectrum of FGF14-related late-onset ataxia: predominant tremor and cognitive decline as key features of SCA27A.

Journal of neurology·2026
Same author

Long-Duration Response to Levodopa in the PPMI-Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

CSF alpha-Synuclein Seed Amplification Assay results in routine clinically collected samples.

Journal of Parkinson's disease·2026
Same author

Alpha-synuclein quantitative seed amplification assay predicts conversion to dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients.

Movement disorders : official journal of the Movement Disorder Society·2025

Related Experiment Video

Updated: May 9, 2025

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

34.2K

Speech Differences between Multiple System Atrophy and Parkinson's Disease.

Tom Hähnel1, Anna Nemitz1, Katja Schön2

  • 1Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD - Dresden University of Technology, Dresden, Germany.

Movement Disorders Clinical Practice
|May 3, 2025
PubMed
Summary

Speech analysis can differentiate multiple system atrophy (MSA) from Parkinson's disease (PD). Distinct speech patterns in MSA, including pauses and rhythm irregularities, provide a reliable digital biomarker for early diagnosis.

Keywords:
Parkinson's diseasedysarthriamultiple system atrophyspeechvoice

More Related Videos

Targeted Training of Ultrasonic Vocalizations in Aged and Parkinsonian Rats
11:00

Targeted Training of Ultrasonic Vocalizations in Aged and Parkinsonian Rats

Published on: August 8, 2011

19.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.7K

Related Experiment Videos

Last Updated: May 9, 2025

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

34.2K
Targeted Training of Ultrasonic Vocalizations in Aged and Parkinsonian Rats
11:00

Targeted Training of Ultrasonic Vocalizations in Aged and Parkinsonian Rats

Published on: August 8, 2011

19.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.7K

Area of Science:

  • Neurology
  • Speech-Language Pathology
  • Biomarker Discovery

Background:

  • Distinguishing early Parkinson's disease (PD) from multiple system atrophy (MSA) is clinically challenging.
  • Speech characteristics are recognized digital biomarkers for PD and ataxia, but data for MSA is scarce.

Purpose of the Study:

  • To investigate the utility of speech characteristics as a digital biomarker for differentiating MSA from PD.
  • To assess if speech analysis can aid in early diagnosis of neurodegenerative conditions.

Main Methods:

  • Speech assessments including text reading, sustained phonation, and diadochokinetic tasks were performed on 21 MSA and 23 PD patients.
  • Speech features were extracted using Praat software for detailed acoustic analysis.

Main Results:

  • Three key speech factors differentiated MSA and PD.
  • MSA speech showed increased reading pauses, pitch variability, syllable duration, and irregular rhythm (ROC-AUC 0.89).
  • Speech characteristics correlated significantly with motor impairment and overall disease severity.

Conclusions:

  • Speech analysis accurately differentiates MSA from PD.
  • Speech patterns offer a promising, non-invasive digital biomarker for early differential diagnosis in neurodegenerative diseases.